Active Ingredient(s): Sugammadex
FDA Approved: * December 15, 2015
Pharm Company: * ORGANON USA INC
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Bridion Overview

Sugammadex (Org 25969, tradename Bridion) is an agent for the reversal of neuromuscular blockade induced by rocuronium and vecuronium[1] in general anaesthesia. It is the first selective relaxant binding agent (SRBA). Contents 1 Medical uses 2 Pharmacology 2.1 Pharmacodynamics 3 Efficacy 4 Tolerability 5 History 6 References Medical uses Sugammadex is used to reverse neuromuscular blockade after administration of the aminosterioid non-depolarizing neuromuscular-bl...

Read more Bridion Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Bridion Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 100mg/ml
  • Solution: 200mg/2ml (100mg/ml), 500mg/5ml (100mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bridion: (3 results)

Sorted by National Drug Code
  • 0006-5423 Bridion 100 mg/ml Intravenous Injection, Solution by Merck Sharp & Dohme Corp.
  • 0006-5425 Bridion 100 mg/ml Intravenous Injection, Solution by Merck Sharp & Dohme Corp.
  • 71872-7187 Bridion 100 mg/ml Intravenous Injection, Solution by Medical Purchasing Solutions, LLC

Other drugs which contain Sugammadex or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 5 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA